0001209191-23-038481.txt : 20230620
0001209191-23-038481.hdr.sgml : 20230620
20230620170401
ACCESSION NUMBER: 0001209191-23-038481
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spaventa Andrew
CENTRAL INDEX KEY: 0001859701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40443
FILM NUMBER: 231026129
MAIL ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Singular Genomics Systems, Inc.
CENTRAL INDEX KEY: 0001850906
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 812948451
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3010 SCIENCE PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 333-7830
MAIL ADDRESS:
STREET 1: 3010 SCIENCE PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-15
0
0001850906
Singular Genomics Systems, Inc.
OMIC
0001859701
Spaventa Andrew
3010 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-06-15
4
M
0
14583
A
24349
D
Common Stock
2023-06-15
4
G
0
14583
0.00
D
9766
D
Common Stock
2023-06-15
4
G
0
14583
0.00
A
3928154
I
By The Andrew K. Spaventa Living Trust dated April 9, 2014
Restricted Stock Units
2023-06-15
4
M
0
14583
D
Common Stock
14583
218750
D
Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.
/s/ Dalen Meeter, Attorney-in-Fact
2023-06-20